VPA-17605-39273
4 vaccinations
1 coded response
28 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 105 / NY
- Registered
- 2021-10-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Dose 1 — Pfizer-BioNTech
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-10-31
Registered in v-safe
-
2021-10-31
Dose 3 — Pfizer-BioNTech
- 2021-10-31
- 2021-11-01
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-14
- 2021-11-21
- 2021-11-28
- 2021-12-05
- 2021-12-12
- 2022-01-30
- 2022-05-01
-
2022-10-07
Dose 4 — Pfizer-BioNTech
- 2022-10-07
- 2022-10-08
- 2022-10-09
-
2022-10-10
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-10-11
- 2022-10-16
- 2022-10-21
- 2022-10-28
- 2022-11-04
- 2022-11-13
- 2022-11-18
-
2023-01-06
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | No |
| 2 | 2021-02-03 | Pfizer-BioNTech | No |
| 3 | 2021-10-31 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release